臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"liu t h"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 41-90 / 291 (共6页)
1 2 3 4 5 6 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-09-01T01:54:16Z	Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation	Chen K.-F.; Yu H.-C.; Liu T.-H.; Lee S.-S.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:12Z	Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3	Chen K.-F.; Tai W.-T.; Liu T.-H.; Huang H.-P.; Lin Y.-C.; Shiau C.-W.; Li P.-K.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:11Z	CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells	Chen K.-F.; Liu C.-Y.; Lin Y.-C.; Yu H.-C.; Liu T.-H.; Hou D.-R.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:43Z	Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma	Shao Y.-Y.; Liu T.-H.; Lee Y.-H.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:24Z	Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment	Lu L.-C.; Lee Y.-H.; Chang C.-J.; Shun C.-T.; Fang C.-Y.; Shao Y.-Y.; Liu T.-H.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏	2021-08-31T06:29:23Z	Considerations of heterogeneity in clinical trials for hepatocellular carcinoma	Liu T.-H.; Shao Y.-Y.; Lu L.-C.; Shen Y.-C.; Hsu C.; Lin Z.-Z.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:21Z	Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma	Shao Y.-Y.; Liu T.-H.; Hsu C.; Lu L.-C.; Shen Y.-C.; Lin Z.-Z.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏	2021-08-31T06:29:21Z	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏	2021-08-18T07:39:05Z	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; JHE-CYUAN GUO; Liu T.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-08-11T03:46:37Z	Considerations of heterogeneity in clinical trials for hepatocellular carcinoma	Liu T.-H.; Shao Y.-Y.; Lu L.-C.; Shen Y.-C.; Hsu C.; ZHONG-ZHE LIN; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-08-11T03:46:36Z	Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma	Shao Y.-Y.; Liu T.-H.; Hsu C.; Lu L.-C.; Shen Y.-C.; ZHONG-ZHE LIN; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2021-08-05T02:40:30Z	Integrated Assessment of Pile Driving Noise for Offshore Wind Farm in Western Taiwan	Liu T.-H;Hu W.-C;Chen C.-F;Hwang W.-S;Wu C.-H.; Liu T.-H; Hu W.-C; Chen C.-F; Hwang W.-S; Wu C.-H.; CHI-FANG CHEN
臺大學術典藏	2021-07-16T06:18:16Z	Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation	Chen K.-F.; Yu H.-C.; Liu T.-H.; SHOEI-SHENG LEE; Chen P.-J.; Cheng A.-L.
臺大學術典藏	2021-07-03T03:34:45Z	Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation	Chen K.-F.; Yu H.-C.; Liu T.-H.; Lee S.-S.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏	2021-07-03T03:34:40Z	CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells	Chen K.-F.; Liu C.-Y.; Lin Y.-C.; Yu H.-C.; Liu T.-H.; Hou D.-R.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏	2021-07-03T03:34:40Z	Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3	Chen K.-F.; Tai W.-T.; Liu T.-H.; Huang H.-P.; Lin Y.-C.; Shiau C.-W.; Li P.-K.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏	2021-06-03T06:50:19Z	Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3	Chen K.-F.; Tai W.-T.; Liu T.-H.; HSIANG-PO HUANG; Lin Y.-C.; Shiau C.-W.; Li P.-K.; Chen P.-J.; Cheng A.-L.
臺大學術典藏	2021-04-27T08:36:00Z	Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study	Lee M.-R.; Yu K.-L.; HUNG-YANG KUO; Liu T.-H.; Ko J.-C.; Tsai J.-S.; Wang J.-Y.
臺大學術典藏	2021-04-27T08:11:49Z	Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study	Lee M.-R.; Yu K.-L.; HUNG-YANG KUO; Liu T.-H.; Ko J.-C.; Tsai J.-S.; Wang J.-Y.
臺大學術典藏	2021-04-15T06:33:37Z	Urinary trypsinogen-2 level and local complications of acute pancreatitis	Wu H.-C.; Wang H.-P.; Chen C.-C.; Wu C.-H.; Liu T.-H.; Wang C.-H.; Shih L.-N.; WEI-CHIH LIAO
臺大學術典藏	2021-03-18T02:02:23Z	Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment	Lu L.-C.;Lee Y.-H.;Chang C.-J.;Chia-Tung Shun;Fang C.-Y.;Shao Y.-Y.;Liu T.-H.;Cheng A.-L.;Hsu C.-H.; Lu L.-C.; Lee Y.-H.; Chang C.-J.; CHIA-TUNG SHUN; Fang C.-Y.; Shao Y.-Y.; Liu T.-H.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2021-03-15T07:44:44Z	Considerations of heterogeneity in clinical trials for hepatocellular carcinoma	Liu T.-H.;Shao Y.-Y.;Li-Chun Lu;Shen Y.-C.;Hsu C.;Lin Z.-Z.;Hsu C.-H.;Cheng A.-L.; Liu T.-H.; Shao Y.-Y.; LI-CHUN LU; Shen Y.-C.; Hsu C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-15T07:44:44Z	Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment	Li-Chun Lu;Lee Y.-H.;Chang C.-J.;Shun C.-T.;Fang C.-Y.;Shao Y.-Y.;Liu T.-H.;Cheng A.-L.;Hsu C.-H.; LI-CHUN LU; Lee Y.-H.; Chang C.-J.; Shun C.-T.; Fang C.-Y.; Shao Y.-Y.; Liu T.-H.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2021-03-15T07:44:43Z	Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma	Shao Y.-Y.;Liu T.-H.;Hsu C.;Li-Chun Lu;Shen Y.-C.;Lin Z.-Z.;Cheng A.-L.;Hsu C.-H.; Shao Y.-Y.; Liu T.-H.; Hsu C.; LI-CHUN LU; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2021-03-15T07:44:43Z	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Li-Chun Lu;Hsu C.;Shao Y.-Y.;Chao Y.;Yen C.-J.;Shih I.-L.;Hung Y.-P.;Chang C.-J.;Shen Y.-C.;Guo J.-C.;Liu T.-H.;Hsu C.-H.;Cheng A.-L.; LI-CHUN LU; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-11T08:34:17Z	Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study	Lee M.-R.;Yu K.-L.;Kuo H.-Y.;Liu T.-H.;Jen-Chang Ko;Tsai J.-S.;Wang J.-Y.; MENG-RUI LEE; KAI-LUN YU; HUNG-YANG KUO; Tsung-Hao Liu; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y.
臺大學術典藏	2021-03-11T08:29:32Z	Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study	Lee M.-R.; Yu K.-L.; Kuo H.-Y.; Liu T.-H.; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y.
臺大學術典藏	2021-03-11T07:58:27Z	Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study	Lee M.-R.; Yu K.-L.; Kuo H.-Y.; Liu T.-H.; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y.
臺大學術典藏	2021-03-09T05:18:31Z	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Ying-Chun Shen; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:31Z	Considerations of heterogeneity in clinical trials for hepatocellular carcinoma	Liu T.-H.; Shao Y.-Y.; Lu L.-C.; Ying-Chun Shen; Hsu C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-02-25T07:00:57Z	It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade	Liu T.-H.; YU-YUN SHAO; Hsu C.-H.
臺大學術典藏	2021-02-19T06:52:25Z	It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade	Liu T.-H.;Shao Y.-Y.;Chih-Hung Hsu; Liu T.-H.; Shao Y.-Y.; CHIH-HUNG HSU
臺大學術典藏	2021-02-18T08:38:07Z	A case of human infection with Anisakis simplex in Taiwan	Li S.-W.; Shiao S.-H.; Weng S.-C.; Liu T.-H.; Su K.-E.; CHIEN-CHUAN CHEN
臺大學術典藏	2021-02-18T02:33:48Z	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Lu L.-C.;Shao Y.-Y.;Chao Y.;Yen C.-J.;Shih I.-L.;Hung Y.-P.;Chang C.-J.;Shen Y.-C.;Guo J.-C.;Liu T.-H.;Chiun Hsu;Cheng A.-L.; Lu L.-C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Chiun Hsu; Cheng A.-L.
臺大學術典藏	2021-02-18T02:33:48Z	Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma	Shao Y.-Y.;Liu T.-H.;Chiun Hsu;Lu L.-C.;Shen Y.-C.;Lin Z.-Z.;Cheng A.-L.; Shao Y.-Y.; Liu T.-H.; Chiun Hsu; Lu L.-C.; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L.
臺大學術典藏	2021-02-18T01:45:21Z	Novel systemic therapy for hepatocellular carcinoma	Dong Y.;Liu T.-H.;Yau T.;Chiun Hsu; Dong Y.; Liu T.-H.; Yau T.; Chiun Hsu
臺大學術典藏	2021-02-04T07:33:05Z	Doses of hepatitis B revaccination needed for the seronegative youths to be seropositive to antibody against hepatitis B surface antigen	Jan C.-F.;Liu T.-H.;Ho C.-H.;Chien Y.-C.;Chang C.-J.;Fei-Ran Guo;Huang K.-C.; Jan C.-F.; Liu T.-H.; Ho C.-H.; Chien Y.-C.; Chang C.-J.; FEI-RAN GUO; Huang K.-C.
臺大學術典藏	2021-01-15T03:46:25Z	Urinary trypsinogen-2 level and local complications of acute pancreatitis	Wu H.-C.; HSIU-PO WANG; Chen C.-C.; Wu C.-H.; Liu T.-H.; Wang C.-H.; Shih L.-N.; Liao W.-C.
臺大學術典藏	2021-01-14T06:25:55Z	Doses of hepatitis B revaccination needed for the seronegative youths to be seropositive to antibody against hepatitis B surface antigen	Chyi-Feng Jan;Liu T.-H.;Ho C.-H.;Chien Y.-C.;Chang C.-J.;Guo F.-R.;Huang K.-C.; CHYI-FENG JAN; Liu T.-H.; Ho C.-H.; Chien Y.-C.; Chang C.-J.; Guo F.-R.; Huang K.-C.
臺大學術典藏	2021-01-14T03:08:40Z	Doses of hepatitis B revaccination needed for the seronegative youths to be seropositive to antibody against hepatitis B surface antigen	Jan C.-F.; Liu T.-H.; Ho C.-H.; Chien Y.-C.; Chang C.-J.; Guo F.-R.; KUO-CHIN HUANG
臺大學術典藏	2021-01-12T05:55:05Z	Entrenchment and Creativity in Chinese Quadrasyllabic Idiomatic Expressions	Hsieh, S.-K.;Chou, T.-L.;Lee, C.-L.;Su, I-W.;Lu, C.-R.;Liu, T.-H.;Tsai, I-N.;T'sou, B.; Tsai, I-Ni; Hsieh, S.-K.; I-NI TSAI
臺大學術典藏	2021-01-12T05:55:04Z	Entrenchment in Chinese Quadra-syllabic Idiomatic Expressions: A fMRI Study	Hsieh, S.-K.;Chou, T.-L.;Tseng, Y.-H.;Chiang, C.-Y.;Lee, C.-L.;Liu, T.-H.;Lu, C.-R.;Tsai, I-N.;Su, I-W.; Tsai, I-Ni; Hsieh, S.-K.; I-NI TSAI
臺大學術典藏	2021-01-12T05:55:04Z	Effects of Frequency and Construction on the Interpretation of Chinese Quadrisyllabic Idiomatic Expressions: An fMRI Study	Liu, T.-H.;Su, I-W.;Lai, C.-H.;Hsieh, S.-K.;Lee, C.-L.;Lu, C.-R.;Tsai, I-N.;Chou, T.-L.; Tsai, I-Ni; Liu, T.-H.; I-NI TSAI
臺大學術典藏	2021-01-12T05:55:04Z	Right Hemisphere Contribution in Syntactic Category Processing in L2 _ERP and fMRI Data from Learners of Mandarin Chinese	Lai, C.-H.;Yeh, C.;Chen, P.-H.;Lee, C.-L.;Hsieh, S.-K.;Su, I-W.;Liu, T.-H.;Lu, C.-R.;Tsai, I-N.;Chou, T.-L.; Tsai, I-Ni; Lai, C.-H.; I-NI TSAI
臺大學術典藏	2021-01-12T03:00:18Z	Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study	Ko J.-C.; Kuo H.-Y.; Liu T.-H.; KAI-LUN YU; Lee M.-R.; Tsai J.-S.; Wang J.-Y.
臺大學術典藏	2021-01-08T01:57:12Z	Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study	Wang J.-Y.; MENG-RUI LEE; Yu K.-L.; Kuo H.-Y.; Liu T.-H.; Ko J.-C.; Tsai J.-S.
國立成功大學	2021	Optical, Microstructure, and Electromagnetic Properties of (1 − x)ZnO − xCuO Powders Prepared Using Two-Stage Sintering and Direct Synthesis	Liu, T.-H.;Hung, F.-Y.;Chen, Chen C.-H.;Chen, K.-J.
臺大學術典藏	2020-12-15T06:29:56Z	Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study	Lee M.-R.;Yu K.-L.;Kuo H.-Y.;Liu T.-H.;Ko J.-C.;Jaw-Shiun Tsai;Wang J.-Y.; Lee M.-R.; Yu K.-L.; Kuo H.-Y.; Liu T.-H.; Ko J.-C.; JAW-SHIUN TSAI; Wang J.-Y.
臺大學術典藏	2020-11-27T03:28:33Z	Urinary trypsinogen-2 level and local complications of acute pancreatitis	Wu H.-C.; Wang H.-P.; CHIEH-CHANG CHEN; Wu C.-H.; Liu T.-H.; Wang C.-H.; Shih L.-N.; Liao W.-C.
臺大學術典藏	2020-11-18T05:27:33Z	CUX2, BRAP and ALDH2 are associated with metabolic traits in people with excessive alcohol consumption	Chen I.-C.; PO-HSIU KUO; Yang A.C.; Tsai S.-J.; Liu T.-H.; Liu H.-J.; Lan T.-H.; Chen H.-M.; Huang H.-N.; Chung R.-H.; Liu Y.-L.

显示项目 41-90 / 291 (共6页)
1 2 3 4 5 6 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 51833553 在线人数 : 1033 教育部委托研究计画计画执行:国立台湾大学图书馆